Exendo Epigenomics SRL
Exendo Epigenomics reported total assets of 328,329 € at the end of the 2025 financial year (annual accounts filed with the NBB on 31 Jul 2026).
The score of Exendo Epigenomics shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +203 % Total assets +109 %
Accounts of the company itself (not consolidated).
The full file covers 8 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Exendo Epigenomics's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 224,361 € | ||||
| Equity | 307,434 € | ||||
| Cash | 15,063 € | ||||
| EBITDA | 304,111 € | ||||
| Total assets | 328,329 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 31 Jul 2026
- Year ended 31 Dec 2024filed on 30 Jun 2025
- Year ended 31 Dec 2023filed on 26 Jul 2024
- Year ended 31 Dec 2022filed on 22 Aug 2023
- Year ended 31 Dec 2021filed on 28 Jun 2022
Exendo Epigenomics's financial analysis
- Solvency93.6%sector median: 47.4%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Exendo Epigenomics
Exendo Epigenomics's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0838.650.023
- VAT number
- BE0838650023
- Peppol
- Registered · 0208:0838650023 · as of 11 Nov 2026
- Legal form
- SRL
- Incorporated
- 11 Aug 2011
- Registered office
- 2200 Herentals
- Latest accounts
- 2025 · filed on 31 Jul 2026
- Activity
- Retail sale of medical and orthopaedic goods, except corrective glasses, lenses and sunglasses (NACE 47741)
Exendo Epigenomics (SRL) has been based in Herentals since 2011, active in: retail sale of medical and orthopaedic goods, except corrective glasses, lenses and sunglasses. For 2025, it reports a net profit of 224,361 € and equity of 307,434 €; its revenue is not published. Its solvency stands at 93.6%, above the median of its sector (47.4%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Exendo Epigenomics
Companies in the same business, of comparable size and area, outside its group.
- Orthovalo Retail sale of medical and orthopaedic goods Herselt · balance sheet 303,805 €
- Symphonie Pochet Retail sale of medical and orthopaedic goods Ciney · balance sheet 354,138 €
- Hoorcentrum Dekelver Retail sale of medical and orthopaedic goods Ronse · balance sheet 352,117 €
- VBrep Retail sale of medical and orthopaedic goods Gerpinnes · balance sheet 350,554 €
- Dental Sud Retail sale of medical and orthopaedic goods Namur · balance sheet 34,848 €
- N.W.S. Retail sale of medical and orthopaedic goods Dilbeek · balance sheet 256,164 €
- Cabinet Infirmier Falisse-Audin Retail sale of medical and orthopaedic goods Charleroi · balance sheet 257,182 €
- Toba Company Retail sale of medical and orthopaedic goods Ninove · balance sheet 294,918 €
Frequently asked questions about Exendo Epigenomics
What is the revenue of Exendo Epigenomics?
Exendo Epigenomics files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Exendo Epigenomics?
In Belgium, the VAT number is the company number prefixed with BE: BE0838650023 for Exendo Epigenomics, if the company is VAT-registered. Its company number (CBE) is 0838.650.023.
Where is the registered office of Exendo Epigenomics?
According to the CBE register, the registered office of Exendo Epigenomics is in 2200 Herentals.
What is the equity of Exendo Epigenomics?
At the close of the 2025 financial year, the equity of Exendo Epigenomics amounts to 307,434 €, a solvency of 93.6% of total assets.
Who manages Exendo Epigenomics?
The register lists 2 active mandates at Exendo Epigenomics. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Exendo Epigenomics
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →